Menu
Back to User profile » Dr Legese Chelkeba
Papers published by Dr Legese Chelkeba:
Treatment Outcome and Associated Factors of Neonatal Sepsis at Mizan Tepi University Teaching Hospital, South West Ethiopia: A Prospective Observational Study
Wale A, Chelkeba L, Wobie Y, Abebe A
Pediatric Health, Medicine and Therapeutics 2021, 12:467-479
Published Date: 11 September 2021
Prevalence and Impact of Metabolic Syndrome on Short-Term Prognosis in Patients with Acute Coronary Syndrome: Prospective Cohort Study
Fanta K, Daba FB, Asefa ET, Chelkeba L, Melaku T
Diabetes, Metabolic Syndrome and Obesity 2021, 14:3253-3262
Published Date: 15 July 2021
Evaluation of Adult Outpatient Antibiotics Use at Jimma Medical Center (with Defined Daily Doses for Usage Metrics)
Melaku T, Gashaw M, Chelkeba L, Berhane M, Bekele S, Lemi G, Wakjira T, Tesfaw G, Mekonnen Z, Ali S, Kroidl A, Wieser A, Froeschl G, Gudina EK
Infection and Drug Resistance 2021, 14:1649-1658
Published Date: 28 April 2021
Gram-Negative Bacteria Isolates and Their Antibiotic-Resistance Patterns in Patients with Wound Infection in Ethiopia: A Systematic Review and Meta-Analysis
Chelkeba L, Melaku T, Mega TA
Infection and Drug Resistance 2021, 14:277-302
Published Date: 29 January 2021
Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming Co-Epidemics
Melaku T, Chelkeba L, Mekonnen Z, Kumela K
Diabetes, Metabolic Syndrome and Obesity 2020, 13:4379-4399
Published Date: 17 November 2020
Clinical, Echocardiographic Characteristics and Management Practices in Patients with Rheumatic Valvular Heart Disease
Mulugeta T, Kumela K, Chelkeba L
Open Access Rheumatology: Research and Reviews 2020, 12:233-239
Published Date: 7 October 2020
Health-Related Quality of Life Among People Living with Human Immunodeficiency Virus on Highly Active Antiretroviral Therapy in Ethiopia: PROQOL-HIV Based Survey
Melaku T, Mamo G, Chelkeba L, Chanie T
Patient Related Outcome Measures 2020, 11:73-86
Published Date: 5 March 2020